Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

61.16
Delayed Data
As of Feb 16
 +0.52 / +0.86%
Today’s Change
51.05
Today|||52-Week Range
135.59
+4.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues1.7M2.8M25.0M131.0M
 
 
 
 
 
Cost of Goods Sold------1.4M
 
 
Depreciation And Amortization442.8K1.7M3.8M--
 
 
 
 
 
Operating ExpensesGross Income------129.6M
 
 
General Expenses114.5M230.2M378.7M465.2M
 
 
 
 
 
Research And Development80.3M128.2M153.9M191.5M
 
 
 
 
 
Total Operating Expenses114.9M231.9M382.5M466.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-113.2M-229.2M-357.5M-335.6M
 
 
 
 
 
Extraordinary Charge-170.8M0.00-45.0M--
 
 
 
Interest Expense On Debt0.000.0014.2M29.3M
 
 
 
Other Expenses776.1K2.7M3.9M4.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-283.2M-226.4M-412.8M-360.4M
 
 
 
 
 
Net Income-283.2M-226.4M-412.8M-360.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.8M23.7M24.7M25.1M
 
 
 
 
 
Shares To Calculate EPS Diluted20.8M23.7M24.7M25.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.63-$9.56-$16.74-$14.38
 
 
 
 
 
EPS Diluted-$13.63-$9.56-$16.74-$14.38